Early use of intravenous methylprednisolone is associated with attenuation of drug challenge reactions in patients with severe cutaneous adverse drug reactions

Authors:

Abstract
No abstract available
Funding Information
  • European Commission (TMA2017SF-1981)
  • National Institute of Allergy and Infectious Diseases (R01AI152183)
  • South African Medical Research Council
  • National Research Foundation
  • Fogarty International Center (K43TW011178-04)

This publication has 7 references indexed in Scilit: